Opioid Risk Management

Access important tools that help predict and monitor patient response to opioid medications.

Electronic Assessments

PainCAS is the only clinical tool of its kind to continually assess benefits and risks associated with opioid therapy throughout the entire patient journey. It increases patient engagement by providing individualized provider and patient reports, improves treatment outcomes by facilitating active measurement of function, and improves patient safety through validated, real-time risk assessments.

PainCAS eliminates the need for paper scoring and replaces the traditional SOAPP-R and COMM with shortened electronic versions, the SOAPP-8 and COMM-9.

About the SOAPP-8
The Screener and Opioid Assessment for Patients in Pain (SOAPP®) is a brief self-report tool to facilitate assessment and planning for chronic pain patients being considered for long-term opioid treatment.

  • The new electronic SOAPP-8 includes eight items which have been identified as being the strongest predictors of aberrant drug-related behavior.  Importantly, these eight items are able to correctly identify which patients will engage in aberrant medication related behavior with nearly 80% accuracy.  SOAPP-8 maintains the same predictive accuracy while reducing the test length by 67%.

About the COMM-9
The Current Opioid Misuse Measure (COMM®) is a self-report screener that helps clinicians identify whether a patient, currently on long-term opioid therapy, may be engaging in aberrant opioid-related behavior. In contrast, the Screener and Opioid Assessment for Patients with Pain (SOAPP) is intended to predict which patients, being considered for long-term opioid therapy, may exhibit aberrant medications behaviors in the future. Since the COMM examines current misuse, it is ideal for helping clinicians monitor patients’ risk of aberrant medication-related behaviors over the course of treatment.